| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/1998 | WO1998016250A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 04/23/1998 | WO1998016249A1 Methods and compositions for immunomodulation |
| 04/23/1998 | WO1998016247A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/23/1998 | WO1998016246A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | WO1998016245A1 Method of autoantibody assay |
| 04/23/1998 | WO1998016244A1 Medicine as an aid for hypothermia |
| 04/23/1998 | WO1998016243A1 Uses of keratinocyte growth factor-2 |
| 04/23/1998 | WO1998016242A1 Method of enhancing the delivery of growth factors |
| 04/23/1998 | WO1998016241A1 Method of disrupting cellular adhesion |
| 04/23/1998 | WO1998016240A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/23/1998 | WO1998016235A1 Peripheral blood stem cell-increasing agents containing glycosides |
| 04/23/1998 | WO1998016219A1 The medicine containing triptolide for preventing and/or treating acute graft rejection |
| 04/23/1998 | WO1998016211A1 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens and tumors |
| 04/23/1998 | WO1998016205A2 Stable glassy state powder formulations |
| 04/23/1998 | WO1998016201A1 Therapeutic liposome composition and method |
| 04/23/1998 | WO1998016190A1 STARCH BINDING DOMAINS (SBDs) FOR ORAL CARE PRODUCTS |
| 04/23/1998 | WO1998016185A2 Potassium channel blocking compounds and their use |
| 04/23/1998 | WO1998012225A3 Process for producing a plasma protein-containing medicament |
| 04/23/1998 | WO1998010076A3 Phospholipase d and dna sequences |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | WO1998009657A3 Method for recombinant adeno-associated virus-directed gene therapy |
| 04/23/1998 | WO1998008548A3 Stable radioiodine conjugates and methods for their synthesis |
| 04/23/1998 | WO1998006753A3 P53 mutant |
| 04/23/1998 | WO1998004702A3 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 04/23/1998 | WO1998004686A3 Pro-protein converting enzyme |
| 04/23/1998 | WO1998001149A3 Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule |
| 04/23/1998 | WO1997046585A3 Fragments of leptin (ob protein) |
| 04/23/1998 | WO1997046207A3 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 04/23/1998 | WO1997041225A3 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
| 04/23/1998 | DE19705230C1 Pulmonary surfactant preparation for instillation and oral use |
| 04/23/1998 | DE19643093A1 Verwendung von FasL oder mit FasL transfizierten CD4+/FasL-/TH1-Zellinien zur Behandlung von TH1/TH2-Krankheiten, Verfahren zur Herstellung von CD4+/FasL+/TH1-Zellinien und Stoffzusammensetzungen von FasL und einem oder mehren Cytokinen sowie dessen Verwendung zur Behandlung von TH1/TH2-Krankheiten Use of FasL or FasL transfected CD4 + / FasL / TH1 cell lines for the treatment of Th1 / Th2 diseases, processes for the production of CD4 + / FasL + / TH1-cell lines and compositions of FasL and to one or more cytokines, as well as its use for the treatment of Th1 / Th2 diseases |
| 04/23/1998 | CA2452540A1 Keratinocyte growth factor-2 products |
| 04/23/1998 | CA2269075A1 Method of enhancing the delivery of growth factors |
| 04/23/1998 | CA2268381A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268340A1 Methods and compositions for immunomodulation |
| 04/23/1998 | CA2268281A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268270A1 Heterocyclic derivatives as factor xa inhibitors |
| 04/23/1998 | CA2268264A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268011A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 04/23/1998 | CA2268008A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | CA2268007A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | CA2267977A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | CA2267173A1 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens and tumors |
| 04/23/1998 | CA2267110A1 Fanconi gene i |
| 04/23/1998 | CA2266848A1 Method for producing an igm preparation for intravenous application |
| 04/23/1998 | CA2265481A1 Novel penicillin binding protein from streptococcus pneumoniae |
| 04/22/1998 | EP0837138A2 Novel topoisomerase III |
| 04/22/1998 | EP0837137A2 Novel topoisomerase III |
| 04/22/1998 | EP0837136A2 Novel topoisomerase I |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837132A2 Novel penicillin binding protein from streptococcus pneumoniae |
| 04/22/1998 | EP0837131A2 Staphylococcus fibronectin binding protein compounds |
| 04/22/1998 | EP0837130A2 M protein analogue from Streptococcus pneumoniae |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837128A2 Human G-protein coupled receptor, HLYAZ61 |
| 04/22/1998 | EP0837127A2 Hereditary multiple exostose gene, Ext2 |
| 04/22/1998 | EP0837074A2 Biologically active fibronectin fragment as cancer metastasis inhibitor |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0837072A2 Lys (B28) insulins. Human insulin analogues |
| 04/22/1998 | EP0837071A1 Tripeptide antithrombotic agents |
| 04/22/1998 | EP0836853A1 Use of bradykinin antagonists for the manufacture of a medicament for treating Alzheimer's disease |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836647A2 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836620A1 Anti-obesity proteins |
| 04/22/1998 | EP0836619A1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 04/22/1998 | EP0836618A1 Radiometal-binding analogues of leutenizing hormone releasing hormone |
| 04/22/1998 | EP0836617A1 Parevins and tachytegrins |
| 04/22/1998 | EP0836616A1 Macrolides |
| 04/22/1998 | EP0836615A1 New thrombin inhibitors, their preparation and use |
| 04/22/1998 | EP0836614A1 Catalytic dna |
| 04/22/1998 | EP0836481A1 Parasitic helminth venom allergen antigen 5-like genes and proteins |
| 04/22/1998 | EP0836480A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof |
| 04/22/1998 | EP0836479A2 Methods for treating diabetes |
| 04/22/1998 | EP0836383A1 Combinations of inhibitors of farnesyl-protein transferase |
| 04/22/1998 | EP0836380A1 Fgf9 as a specific ligand for fgfr3 |
| 04/22/1998 | EP0820285A4 Methods and compositions for lipidization of hydrophilic molecules |
| 04/22/1998 | EP0721467A4 Use of relaxin as an analgesic and palliative for intractable pain |
| 04/22/1998 | EP0661933B1 Morphogen-enriched dietary composition |
| 04/22/1998 | EP0627913B1 Facilitated oxygen delivery in conjunction with hemodilution |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | EP0241487B1 Method and means for sorting and identifying biological information |
| 04/22/1998 | CN1179780A Peptides with growth promotion properties |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179725A Modulation of cell proliferation and wound healing |
| 04/22/1998 | CN1179724A HCG Liquid formulations |
| 04/22/1998 | CN1179723A Mucosal preparation containing physiologically active peptide |
| 04/22/1998 | CN1179712A Medicine feeding system containing angiotensin converting enzyme (ACE) inhibitors |
| 04/22/1998 | CN1179306A Medicine containing tripdiolide for preventing and treating graft acute rejection |
| 04/21/1998 | US5741899 Chimeric dna sequence encoding membrane bound protein which can be expressed in host cell to initiate proliferation |
| 04/21/1998 | US5741895 Identification of cell density signal molecule |
| 04/21/1998 | US5741894 Heating crosslinked and uncrosslinked hemoglobin in presence of nonstoichiometric amounts of oxygen resulting in precipitation of uncrosslinked hemoglobin |
| 04/21/1998 | US5741893 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 04/21/1998 | US5741892 Pentapeptides as antitumor agents |
| 04/21/1998 | US5741891 Pulmonary surfactant peptide solubilization process |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741808 Protein kinase inhibitors for treatmen of neurological disorders |
| 04/21/1998 | US5741799 Heterocyclic thrombin inhibitors |